Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Susskind

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Imprint|April 1, 1982
ChoicesB Susskind
Arzneimittel-Forschung|January 1, 1985
Modulation of in vitro cellular immune response by histamine agonists or antagonists in murine speciesS French, M Walker, B Susskind, et al.
The Journal of Clinical Investigation|March 1, 1993
Analysis of T cell responses in liver allograft recipients. Evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulationJ M Mathew, J W Marsh, B Susskind, et al.
The Journal of Biological Chemistry|January 25, 1977
An energy-conserving pyruvate-to-acetate pathway in Entamoeba histolytica. Pyruvate synthase and a new acetate thiokinaseR E Reeves, L G Warren, B Susskind, et al.
Transplantation Proceedings|March 20, 1999
Correlation of pretransplant allosensitization with severity of rejection biopsyJ Clark, R Kerman, B Susskind, et al.
Transplantation Proceedings|February 1, 1997
Postrenal transplant MLR hypo-responders have fewer rejections and better graft survival than MLR hyper-respondersR H Kerman, B Susskind, S M Katz, et al.
Human Immunology|March 1, 1996
Indirect allorecognition of HLA class I peptides by CD4+ cytolytic T lymphocytesB Susskind, M R Iannotti, M D Shornick, et al.
Transplantation|January 12, 1999
Can an immunologically, nonreactive potential allograft recipient undergo transplantation without a donor-specific crossmatch?R H Kerman, B Susskind, J Ruth, et al.
International Journal of Immunopharmacology|January 1, 1982
Immunoenhancing activity of NPT 15392: a potential immune response modifierV J Merluzzi, M M Walker, N Williams, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 12, 2012
Bortezomib for acute antibody-mediated rejection in liver transplantationF Paterno, M Shiller, G Tillery, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Imprint|April 1, 1982
ChoicesB Susskind
Arzneimittel-Forschung|January 1, 1985
Modulation of in vitro cellular immune response by histamine agonists or antagonists in murine speciesS French, M Walker, B Susskind, et al.
The Journal of Clinical Investigation|March 1, 1993
Analysis of T cell responses in liver allograft recipients. Evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulationJ M Mathew, J W Marsh, B Susskind, et al.
The Journal of Biological Chemistry|January 25, 1977
An energy-conserving pyruvate-to-acetate pathway in Entamoeba histolytica. Pyruvate synthase and a new acetate thiokinaseR E Reeves, L G Warren, B Susskind, et al.
Transplantation Proceedings|March 20, 1999
Correlation of pretransplant allosensitization with severity of rejection biopsyJ Clark, R Kerman, B Susskind, et al.
Transplantation Proceedings|February 1, 1997
Postrenal transplant MLR hypo-responders have fewer rejections and better graft survival than MLR hyper-respondersR H Kerman, B Susskind, S M Katz, et al.
Human Immunology|March 1, 1996
Indirect allorecognition of HLA class I peptides by CD4+ cytolytic T lymphocytesB Susskind, M R Iannotti, M D Shornick, et al.
Transplantation|January 12, 1999
Can an immunologically, nonreactive potential allograft recipient undergo transplantation without a donor-specific crossmatch?R H Kerman, B Susskind, J Ruth, et al.
International Journal of Immunopharmacology|January 1, 1982
Immunoenhancing activity of NPT 15392: a potential immune response modifierV J Merluzzi, M M Walker, N Williams, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 12, 2012
Bortezomib for acute antibody-mediated rejection in liver transplantationF Paterno, M Shiller, G Tillery, et al.
Pageof 3